The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 18, 2022

Filed:

Nov. 14, 2019
Applicant:

Medimmune Limited, Cambridge, GB;

Inventors:

Xing Cheng, Gaithersburg, MD (US);

Danielle Carroll, Cambridge, GB;

Matthew McCourt, Cambridge, GB;

Mark Galinski, Gaithersburg, MD (US);

Hong Jin, Gaithersburg, MD (US);

Assignee:

MEDIMMUNE LIMITED, Cambridge, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/768 (2015.01); C12N 7/04 (2006.01); C07K 14/535 (2006.01); C12N 15/86 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/768 (2013.01); C07K 14/005 (2013.01); C07K 14/535 (2013.01); C12N 7/00 (2013.01); C12N 7/04 (2013.01); C12N 15/86 (2013.01); C12N 2710/16122 (2013.01); C12N 2710/16143 (2013.01); C12N 2760/18122 (2013.01); C12N 2760/18132 (2013.01); C12N 2760/18133 (2013.01); C12N 2760/18143 (2013.01);
Abstract

The present invention provides methods for inducing regression of tumors in human subjects, the methods utilize a modified mesogenic strain of Newcastle disease virus (NDV) with modified F protein cleavage site, which is non-pathogenic to poultry (lentogenic), but exhibits oncolytic properties. The disclosed methods provide safe, effective and reliable means to induce regression of a tumor in an individual in need thereof. These methods overcome the drawbacks of using pathogenic strains of viruses for human therapy.


Find Patent Forward Citations

Loading…